These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12827974)

  • 1. Myelin molecules limiting nervous system plasticity.
    Schnaar RL
    Prog Mol Subcell Biol; 2003; 32():125-42. PubMed ID: 12827974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regeneration and plasticity of the injured central nervous system].
    Yamashita T; Hata K; Yamaguchi A; Kubo T
    Tanpakushitsu Kakusan Koso; 2007 Jan; 52(1):11-7. PubMed ID: 17228835
    [No Abstract]   [Full Text] [Related]  

  • 3. Where no synapses go: gatekeepers of circuit remodeling and synaptic strength.
    Mironova YA; Giger RJ
    Trends Neurosci; 2013 Jun; 36(6):363-73. PubMed ID: 23642707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroscience. It takes more than two to Nogo.
    Woolf CJ; Bloechlinger S
    Science; 2002 Aug; 297(5584):1132-4. PubMed ID: 12183616
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelin-associated inhibitors of axon regeneration.
    Grados-Munro EM; Fournier AE
    J Neurosci Res; 2003 Nov; 74(4):479-85. PubMed ID: 14598291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approaches to spinal cord repair.
    David S; Lacroix S
    Annu Rev Neurosci; 2003; 26():411-40. PubMed ID: 12626698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Axon growth inhibition signals and strategies to treat injuries to the central nervous system].
    Yamashita T
    Tanpakushitsu Kakusan Koso; 2008 Mar; 53(4 Suppl):406-10. PubMed ID: 21089311
    [No Abstract]   [Full Text] [Related]  

  • 9. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
    Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
    Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanism and regulation of axon growth inhibition].
    Yamashita T
    Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nogo: a molecular determinant of axonal growth and regeneration.
    Grandpré T; Strittmatter SM
    Neuroscientist; 2001 Oct; 7(5):377-86. PubMed ID: 11597097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor.
    McGee AW; Yang Y; Fischer QS; Daw NW; Strittmatter SM
    Science; 2005 Sep; 309(5744):2222-6. PubMed ID: 16195464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
    Saha N; Kolev M; Nikolov DB
    Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors for myelin inhibitors: Structures and therapeutic opportunities.
    Cao Z; Gao Y; Deng K; Williams G; Doherty P; Walsh FS
    Mol Cell Neurosci; 2010 Jan; 43(1):1-14. PubMed ID: 19619659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nogo and the Nogo-66 receptor.
    Fournier AE; GrandPré T; Gould G; Wang X; Strittmatter SM
    Prog Brain Res; 2002; 137():361-9. PubMed ID: 12440378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration.
    Sivasankaran R; Pei J; Wang KC; Zhang YP; Shields CB; Xu XM; He Z
    Nat Neurosci; 2004 Mar; 7(3):261-8. PubMed ID: 14770187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming inhibition in the damaged spinal cord.
    Fawcett JW
    J Neurotrauma; 2006; 23(3-4):371-83. PubMed ID: 16629623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory proteins against axon regeneration in the central nervous system].
    Hu JG; Lu PH; Xu XM
    Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury.
    Simonen M; Pedersen V; Weinmann O; Schnell L; Buss A; Ledermann B; Christ F; Sansig G; van der Putten H; Schwab ME
    Neuron; 2003 Apr; 38(2):201-11. PubMed ID: 12718855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.